Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global neurostimulation devices market 3600 synopsis, 2018 – 2032
2.1.1 Regional trends
2.1.2 Product trends
2.1.3 Application trends
Chapter 3 Neurostimulation Devices Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Increasing demand for minimally invasive surgery in developed countries
3.5.1.2 Increasing prevalence of neurological disorders
3.5.1.3 Technological advancements in neurostimulation devices
3.5.1.4 Increasing number of elderly patients with neurological disorders
3.5.1.5 Investments by companies and organizations across the globe
3.5.2 Industry pitfalls & challenges
3.5.2.1 Complications associated with neurostimulation devices
3.5.2.2 Lack of skilled healthcare practitioners
3.6 Growth potential analysis
3.6.1 By product
3.6.2 By application
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company market share analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic outlook matrix, 2022
Chapter 5 Neurostimulation Devices Market Size and Forecast, By Product, 2018-2032 (USD Million)
5.1 Key trends, by product
5.2 Deep brain stimulator
5.3 Gastric electric stimulator
5.4 Spinal cord stimulator
5.5 Sacral nerve stimulator
5.6 Vagus nerve stimulator
5.7 Transcutaneous electrical nerve stimulation (TENS)
5.8 Other products
Chapter 6 Neurostimulation Devices Market Size and Forecast, By Application, 2018-2032 (USD Million)
6.1 Key trends, by application
6.2 Pain management
6.3 Epilepsy
6.4 Essential tremor
6.5 Urinary and fecal incontinence
6.6 Depression
6.7 Dystonia
6.8 Gastroparesis
6.9 Parkinson's disease
6.10 Other applications
Chapter 7 Neurostimulation Devices Market Size and Forecast, By Region, 2018-2032 (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Rest of Latin America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 Rest of Middle East & Africa
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.2 Aleva Neurotherapeutics S.A
8.3 BioControl Medical
8.4 Boston Scientific Corporation
8.5 ElectroCore, Inc.
8.6 Endostim
8.7 Helbling Holding AG
8.8 Innovative Health Solutions, Inc.
8.9 Laborie, Inc.
8.10 LivaNova PLC
8.11 Medtronic plc
8.12 MicroTransponder
8.13 Neuronetics, Inc.
8.14 Parasym Ltd.
8.15 RS Medical
8.16 Synapse Biomedical
8.17 tVNS Technologies GmbH (Cerbomed)
